Endothelial function in chronic congestive heart failure.

[1]  H. Drexler,et al.  Endothelial dysfunction of hindquarter resistance vessels in experimental heart failure. , 1992, The American journal of physiology.

[2]  T. Rector,et al.  Endothelium‐Dependent Vasodilation Is Attenuated in Patients With Heart Failure , 1991, Circulation.

[3]  Y. Tardy,et al.  Evaluation of Arterial Compliance‐Pressure Curves Effect of Antihypertensive Drugs , 1991, Hypertension.

[4]  L. Poston,et al.  Effect of Ouabain on Endothelium‐Dependent Relaxation of Human Resistance Arteries , 1991, Hypertension.

[5]  A. Henderson,et al.  St Cyres lecture. Endothelium in control. , 1991, British heart journal.

[6]  M Arditi,et al.  Non-invasive estimate of the mechanical properties of peripheral arteries from ultrasonic and photoplethysmographic measurements. , 1991, Clinical physics and physiological measurement : an official journal of the Hospital Physicists' Association, Deutsche Gesellschaft fur Medizinische Physik and the European Federation of Organisations for Medical Physics.

[7]  J. Burnett,et al.  The role of endothelium-derived relaxing factor in experimental congestive heart failure , 1991 .

[8]  H. Drexler,et al.  Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. , 1991, Circulation.

[9]  M. Clozel,et al.  Effects of angiotensin converting enzyme inhibitors and of hydralazine on endothelial function in hypertensive rats. , 1990, Hypertension.

[10]  M. Yacoub,et al.  Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries , 1990, The Lancet.

[11]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[12]  A. Takeshita,et al.  Attenuated forearm vasodilative response to intra-arterial atrial natriuretic peptide in patients with heart failure. , 1990, Circulation.

[13]  J. Loscalzo,et al.  Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. , 1990, The Journal of clinical investigation.

[14]  T. Lüscher,et al.  Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Blunted response in essential hypertension. , 1990, Circulation.

[15]  S. Moncada,et al.  EFFECTS OF ENDOTHELIUM-DERIVED NITRIC OXIDE ON PERIPHERAL ARTERIOLAR TONE IN MAN , 1989, The Lancet.

[16]  S Moncada,et al.  Biosynthesis of nitric oxide from L-arginine. A pathway for the regulation of cell function and communication. , 1989, Biochemical pharmacology.

[17]  A. M. Lefer,et al.  Anti-EDRF effect of tumor necrosis factor in isolated, perfused cat carotid arteries. , 1989, The American journal of physiology.

[18]  N. B. Olivier,et al.  Heart failure depresses endothelium-dependent responses in canine femoral artery. , 1989, The American journal of physiology.

[19]  H. Drexler,et al.  Contrasting peripheral short-term and long-term effects of converting enzyme inhibition in patients with congestive heart failure. A double-blind, placebo-controlled trial. , 1989, Circulation.

[20]  V. Miller,et al.  Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. , 1988, The American journal of physiology.

[21]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[22]  P. Ganz,et al.  Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. , 1986, The New England journal of medicine.

[23]  R. Zelis,et al.  Alterations in vasomotor tone in congestive heart failure. , 1982, Progress in cardiovascular diseases.